Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Clarivate Analytics Plc (NY: CLVT ) 5.590 -0.050 (-0.89%) Official Closing Price Updated: 7:00 PM EDT, Jul 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Clarivate Analytics Plc < Previous 1 2 3 Next > Why Is Clarivate Stock Trading Higher Premarket Monday? May 20, 2024 Clarivate Plc launched AI-enhanced Trademark Watch Analyzer at 2024 International Trademark Association Annual Meeting, connecting users to trademark data in 258 countries and territories. Solution... Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Critical Insights From Clarivate Analyst Ratings: What You Need To Know May 09, 2024 Via Benzinga CLVT Stock Earnings: Clarivate Meets EPS, Beats Revenue for Q1 2024 May 08, 2024 CLVT stock results show that Clarivate met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace Analytics Firm Clarivate Acquires AI Start-Up MotionHall - What's On The Cards? March 21, 2024 Clarivate has agreed to acquire the majority of assets of MotionHall, a Silicon Valley technology start-up. MotionHall serves life sciences with vertical artificial intelligence (AI) solutions. The... Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Exor Amplifies Stake In Clarivate, Proposes New Board Member March 04, 2024 Exor N.V. increases stake in Clarivate Plc to 10.1%, with potential to reach 17.5%. Suzanne Heywood to join board, showing strong support for Clarivate's growth and mission. Via Benzinga The Analyst Landscape: 5 Takes On Clarivate February 28, 2024 Via Benzinga Earnings Scheduled For February 27, 2024 February 27, 2024 Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. Via Benzinga Preview: Clarivate's Earnings February 26, 2024 Via Benzinga The Latest Analyst Ratings for Clarivate September 26, 2023 Via Benzinga Where Clarivate Stands With Analysts August 25, 2023 Via Benzinga S&P 500, Nasdaq 100 Dip, Small Caps Surge; Bitcoin Tops $57,000, 2 Biotech Stocks Skyrocket: What's Driving Markets Tuesday? February 27, 2024 On Tuesday, large-cap indices experienced a downturn, while small caps surged, reflecting investor attention on stock valuations. Via Benzinga Topics Stocks Exposures US Equities Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 27, 2024 Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. Via Benzinga 12 Industrials Stocks Moving In Tuesday's Intraday Session February 27, 2024 Via Benzinga 12 Industrials Stocks Moving In Tuesday's Pre-Market Session February 27, 2024 Via Benzinga 12 Industrials Stocks Moving In Tuesday's Pre-Market Session November 07, 2023 Via Benzinga 12 Industrials Stocks Moving In Tuesday's After-Market Session October 17, 2023 Via Benzinga 12 Industrials Stocks Moving In Monday's After-Market Session October 16, 2023 Via Benzinga Clarivate Buys Alethea, Creates Academia And Government Innovation Incubator September 26, 2023 Clarivate PLC (NYSE: CLVT) disclosed the plan to create an Academia and Government Innovation Incubator to Via Benzinga Clarivate Launches AI-Powered Tool For IP Forecasts And Budgets September 20, 2023 Clarivate Plc (NYSE: CLVT) has launched Forecast, the next-generation artificial intelligence (AI)-driven solution designed to enable intellectual property (IP) professionals to efficiently Via Benzinga Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property Have Million-Dollar Gene Therapies Finally Reached An Inflection Point? September 15, 2023 Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions. Via Investor's Business Daily Exposures Product Safety Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023 September 08, 2023 Via Benzinga Adobe To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Friday September 08, 2023 B of A Securities cut the price target for DigitalOcean Holdings, Inc. (NYSE: DOCN) from $47 to $25. B of A Securities analyst Wamsi Mohan downgraded the stock from Buy to Underperform. DigitalOcean... Via Benzinga Planet Labs PBC, GameStop And Other Big Stocks Moving Lower In Friday's Pre-Market Session September 08, 2023 U.S. stock futures traded lower this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga Generative AI Startup AI21 Labs Reaches Unicorn Status With Latest Funding Round August 31, 2023 AI21 Labs, a front-runner in the AI domain specializing in large language models (LLMs), declared the completion of a $155 million Series C fundraiser. Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2023 August 25, 2023 Via Benzinga Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor August 22, 2023 Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence 12 Industrials Stocks Moving In Monday's After-Market Session August 21, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 7, 2023 August 07, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023 August 04, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Friday August 04, 2023 On Friday, 73 companies reached new 52-week lows. Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
